Cancer: The March on Malignancy

The torrents of data flowing out of cancer research and treatment are yielding fresh insight into the disease

Much of the world is ill-equipped to cope with its rising cancer burden and are pushing prevention and screening

Genomics can provide powerful tools against cancer — but only once clinical information can be made broadly available

Clinical studies that group patients according to their molecular profile can make for better and faster drug approval decisions

New research into how and why tumors form, grow and spread is producing better screening tests and more effective remedies with fewer side effects

Carcinogens are all around us, so scientists are broadening their ideas of environmental risk

Effective treatment of cancer requires getting the drugs precisely to the target. Enter the nanoparticle

Despite a huge amount of funding and research, regional and individual differences in cancer trends make it a hard disease to wipe out

Even as cancer therapies improve, basic questions about drug resistance, tumour spread and the role of normal tissue remain unanswered

Tailoring cancer treatment to individual and evolving tumours is the way of the future, but scientists are still hashing out the details

A subterranean species that seems to be cancer-proof is providing promising clues on how we might prevent the disease in humans